Identification and Characterization of a Rare Exon 22 Duplication in CFTR in Two Families
Open Access
- 8 May 2025
- journal article
- case report
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (10) , 4487
Abstract
Accurate genetic diagnosis is essential for appropriate treatment in cystic fibrosis (CF). Large copy number variants like duplications in the CFTR gene are rare and often classified as variants of uncertain significance (VUSs) due to unknown characteristics of the inserted material, complicating diagnosis and treatment decisions. We identified a previously uncharacterized exon 22 duplication (CFTRdup22) in the CFTR gene in two anamnestically unrelated people with CF, both exhibiting a mild phenotype. Initial classification as a VUS was based on standard genetic testing. We employed a custom next-generation sequencing (NGS) panel to determine the exact breakpoints of the duplication and conducted mRNA sequencing to confirm its effect on splicing. DNA and RNA analyses allowed for precise breakpoint determination, confirming that the duplication was in tandem and the reading frame remained intact. This, as well as a residual CFTRdup22 function of ~30% as measured via intestinal current measurement, is consistent with a clinically milder CF phenotype. Collectively, the precise characterization of the variants’ breakpoints, localization and orientation enabled us to reclassify the variant as likely pathogenic. This study highlights the importance of advanced genetic techniques, such as NGS and breakpoint analysis, in accurately identifying CF-causing variants. It underscores the importance of a comprehensive approach and persistence when suspecting a specific genetic condition. This can aid in reclassifying VUSs, providing a definitive diagnosis for the affected family and enabling appropriate therapeutic interventions, including the use of CFTR modulators.Keywords
Funding Information
- Vertex Pharmaceuticals
- German CF foundation
This publication has 27 references indexed in Scilit:
- Every CFTR variant counts – Target-capture based next-generation-sequencing for molecular diagnosis in the German CF RegistryJournal of Cystic Fibrosis, 2023
- The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research settingHuman Genetics, 2020
- Identification of a novel large deletion and other copy number variations in theCFTRgene in patients with Cystic Fibrosis from a multiethnic populationMolecular Genetics & Genomic Medicine, 2019
- Predicting Splicing from Primary Sequence with Deep LearningCell, 2019
- DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genesGenetics in Medicine, 2018
- CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rareCFTRvariantsHuman Mutation, 2017
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsThe American Journal of Human Genetics, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Next-Generation Sequencing of Duplication CNVs Reveals that Most Are Tandem and Some Create Fusion Genes at BreakpointsThe American Journal of Human Genetics, 2015
- Integrative genomics viewerNature Biotechnology, 2011